Background: Venous thromboembolism (VTE) after hip or knee arthroplasty has attracted
increasing attention over the past few decades. However, there is no bibliometric report on …

Background Natural killer (NK) cells are important components of adaptive and innate
immune responses. NK cell subsets have different functions and may play a role in vascular …

Background Venous thromboembolism (VTE) events are infrequent but potentially
catastrophic complications following orthopedic surgery. There is currently a paucity of …

Background The highest risk of developing venous thromboembolism (VTE) is seen in
patients who have undergone orthopedic surgery. One of the most common methods to …

Previous studies showed that adrenomedullin (AM) could be a promising agent for
molecular imaging of the pulmonary circulation, with abundant specific binding sites at the …

This study aimed to assess the impact of enhanced recovery after surgery (ERAS)
intervention in preventing venous thromboembolism (VTE) among postoperative lung …

Background Regression of thrombus in response to treatment with direct oral anticoagulants
(DOACs) in patients with extensive deep vein thrombosis (DVT) has not been fully …

Importance Venous thromboembolism (VTE) surveillance practices in hospitals, but not
adherence to Surgical Care Improvement Program VTE prophylaxis measures, have been …

Introduction Venous thromboembolism (VTE) is a significant cause of morbidity and mortality
following tibial fractures. The risk is as high as 77% without prophylaxis and around 10 …

Apixaban is an anticoagulant used to treat venous thromboembolic disorders. The present
work describes the origin and synthesis of related substances of Apixaban PG ester‐1 and …